NCT03482973View on ClinicalTrials.gov

Pecto-Intercostal Fascial Block for Postoperative Analgesia After Cardiac Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 21, 2018

Primary Completion Date

November 25, 2019

Study Completion Date

November 27, 2019

Conditions
Coronary Artery DiseaseSternal Pain
Interventions
DRUG

Bupivacaine Group

20cc bupivacaine hydrochloride will be administered on each side at two different time points (immediately post operatively and on day 1).

OTHER

Placebo

20cc placebo (0.9% NaCl) will be administered on each side at two different time points (immediately post operatively and on day 1).

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
lead

Beth Israel Deaconess Medical Center

OTHER

NCT03482973 - Pecto-Intercostal Fascial Block for Postoperative Analgesia After Cardiac Surgery | Biotech Hunter | Biotech Hunter